National Health Investors (NHI) is a publicly traded Real Estate sector company. As of September 21, 2026, NHI trades at $67.64 with a market cap of $3.33B and a P/E ratio of 19.49. NHI moved -2.07% today. Year to date, NHI is -11.22%; over the trailing twelve months it is -14.43%. Its 52-week range spans $65.22 to $91.38. Analyst consensus is buy with an average price target of $82.17. Rallies surfaces NHI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest NHI news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $67.64 |
| Market Cap | $3.33B |
| P/E Ratio | 19.49 |
| EPS | $3.47 |
| Dividend Yield | 0.94% |
| 52-Week High | $91.38 |
| 52-Week Low | $65.22 |
| Volume | 299.88K |
| Avg Volume | 0 |
| Revenue (TTM) | $432.12M |
| Net Income | $165.39M |
| Gross Margin | 0.00% |
6 analysts cover NHI: 0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.17.